Reefer madness as pot stock Tilray hits $20bn valuation

Shares go on wild ride after DEA approval for cannabis product capsule
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals